stockrowWaters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.
- Revenue
- +120.9%
- EPS
- −67.0%
- Free cash flow
- −66.7%
- Total debt
- +308.2%
Quarter to September 2026, against a year earlier
Follow WAT
Alert me
Waters Corporation (WAT) Operating cash flow
Waters Corporation's operating cash flow for fiscal 2025 was $652.6M, down 14.4% from $762.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $460.6M. Over the past ten years it has ranged from $573.2M (fiscal 2015) to $790.5M (fiscal 2020); the current reading is higher than 64% of that period. Waters Corporation ranks 15th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $652.6M | (14.38%) |
| FY2024 | $762.1M | 26.43% |
| FY2023 | $602.8M | (1.45%) |
| FY2022 | $611.7M | (18.15%) |
| FY2021 | $747.3M | (5.47%) |
| FY2020 | $790.5M | 22.92% |
| FY2019 | $643.1M | 6.39% |
| FY2018 | $604.4M | (13.36%) |
| FY2017 | $697.6M | 8.51% |
| FY2016 | $642.9M | 12.15% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $98.0M | (51.24%) |
| Jun 2026 | $201.0M | — |
| Mar 2026 | −$3.0M | — |
| Dec 2025 | $164.6M | (12.00%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.7B |
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.2B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation | $460.6M |
| NTRA Natera, Inc. compare | $212.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on WAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement